Physician
Salhadar, Alia
Salhadar, Alia was paid $2.47M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 18% of everything it billed.
33Billing provider infoSALHADAR, ALIA
MAYWOOD, IL 60153
MAYWOOD, IL 60153
33aNPI1235100546assigned 01/27/2006
33bProvider typeAnatomic Pathology Physician
28Total paid$2.47M
24GClaims393,705
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology Physician providers in Illinois
Rank by total paid#4 of 38
Median peer was paid$56K
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 382 | $10K | |
| 2019 | 5,899 | $43K | |
| 2020 | 82,245 | $400K | |
| 2021 | 82,089 | $502K | |
| 2022 | 86,521 | $692K | |
| 2023 | 74,379 | $462K | |
| 2024incomplete | 62,190 | $357K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 18% | 6,119 | 5,739 | $438K |
| 80053 | Comprehensive metabolic panel | 11% | 52,601 | 33,165 | $263K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.0% | 68,403 | 42,586 | $198K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7.0% | 7,268 | 6,361 | $172K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.0% | 3,778 | 3,553 | $148K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.0% | 23,782 | 13,610 | $97K |
| 84484 | 3.4% | 20,818 | 15,331 | $83K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.4% | 1,440 | 991 | $83K |
| 83735 | 2.7% | 18,528 | 7,938 | $67K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.5% | 2,749 | 2,575 | $61K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.5% | 2,732 | 2,556 | $61K |
| 83880 | 2.4% | 5,095 | 4,143 | $59K |
100 more codes
| 87040 | 1.9% | 4,938 | $46K | |
| 83690 | 1.7% | 11,927 | $41K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 1,484 | $38K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 4,570 | $38K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.5% | 6,618 | $36K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 884 | $31K |
| 85027 | 1.2% | 10,221 | $29K | |
| 83605 | 1.1% | 5,771 | $27K | |
| 88342 | 1.0% | 1,400 | $25K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,736 | $21K |
| 85730 | <1% | 6,195 | $20K | |
| 86901 | <1% | 7,500 | $17K | |
| 81001 | <1% | 12,194 | $17K | |
| 84702 | <1% | 3,582 | $16K | |
| 85610 | <1% | 8,173 | $16K | |
| 88307 | <1% | 271 | $16K | |
| 84100 | <1% | 7,511 | $16K | |
| 86850 | <1% | 5,394 | $16K | |
| 85379 | <1% | 3,992 | $15K | |
| 80061 | Lipid panel | <1% | 3,689 | $13K |
| 86900 | <1% | 7,498 | $13K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 238 | $12K |
| 82728 | <1% | 2,773 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,412 | $11K |
| 82077 | <1% | 922 | $10K | |
| 84145 | <1% | 966 | $9K | |
| 82607 | <1% | 1,506 | $9K | |
| 81003 | <1% | 7,334 | $8K | |
| 82746 | <1% | 1,293 | $7K | |
| 83550 | <1% | 1,745 | $7K | |
| 86140 | <1% | 2,749 | $6K | |
| 87075 | <1% | 950 | $6K | |
| 82803 | <1% | 700 | $6K | |
| 82550 | <1% | 1,930 | $6K | |
| 87070 | <1% | 1,687 | $5K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 33 | $5K |
| 80076 | <1% | 1,594 | $5K | |
| 87340 | <1% | 772 | $5K | |
| 83615 | <1% | 1,934 | $5K | |
| 82247 | <1% | 2,184 | $5K | |
| 87088 | <1% | 804 | $5K | |
| 84439 | <1% | 1,056 | $5K | |
| 87641 | <1% | 206 | $5K | |
| 87081 | <1% | 1,483 | $4K | |
| 82805 | <1% | 474 | $4K | |
| 82570 | <1% | 1,661 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 167 | $4K |
| 87806 | <1% | 388 | $4K | |
| 82248 | <1% | 1,979 | $4K | |
| 87210 | <1% | 1,508 | $3K | |
| 87205 | <1% | 1,759 | $3K | |
| 80202 | <1% | 455 | $3K | |
| 86706 | <1% | 426 | $3K | |
| 84132 | <1% | 1,775 | $3K | |
| 87186 | <1% | 438 | $3K | |
| 86704 | <1% | 340 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 169 | $2K |
| 84550 | <1% | 1,304 | $2K | |
| 85652 | <1% | 1,437 | $2K | |
| 88304 | <1% | 116 | $2K | |
| 81025 | <1% | 1,070 | $2K | |
| 86880 | <1% | 560 | $2K | |
| 82962 | <1% | 1,675 | $2K | |
| 82330 | <1% | 250 | $2K | |
| 84112 | <1% | 49 | $2K | |
| 84156 | <1% | 1,221 | $1K | |
| 88341 | <1% | 40 | $1K | |
| 82375 | <1% | 469 | $1K | |
| 85018 | <1% | 1,030 | $1K | |
| 80074 | <1% | 56 | $1K | |
| 86592 | <1% | 498 | $980.00 | |
| 85014 | <1% | 932 | $951.89 | |
| 83540 | <1% | 303 | $945.46 | |
| 83050 | <1% | 470 | $732.08 | |
| 85046 | <1% | 245 | $627.46 | |
| 82140 | <1% | 134 | $597.56 | |
| 82565 | <1% | 255 | $479.01 | |
| 86803 | <1% | 57 | $468.54 | |
| 84300 | <1% | 192 | $443.07 | |
| 86480 | <1% | 14 | $363.58 | |
| 87493 | <1% | 16 | $343.65 | |
| 83655 | <1% | 39 | $233.70 | |
| 82010 | <1% | 90 | $221.90 | |
| 83970 | <1% | 13 | $202.28 | |
| 84703 | <1% | 58 | $196.90 | |
| 80177 | <1% | 36 | $173.15 | |
| 82150 | <1% | 54 | $172.26 | |
| 86870 | <1% | 23 | $164.91 | |
| 87077 | <1% | 609 | $157.42 | |
| 89051 | <1% | 46 | $148.80 | |
| 86038 | <1% | 16 | $79.00 | |
| 80320 | <1% | 504 | $67.50 | |
| 83935 | <1% | 22 | $53.59 | |
| 86762 | <1% | 12 | $49.20 | |
| 87015 | <1% | 13 | $43.20 | |
| 83930 | <1% | 14 | $32.62 | |
| 82977 | <1% | 19 | $29.85 | |
| 84295 | <1% | 19 | $18.64 | |
| 82947 | <1% | 38 | $17.51 | |
| 82435 | <1% | 16 | $4.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.